Christopher Labos: Diet and exercise in a post-Ozempic world

Medications like semaglutide (Ozempic, Wegovy) have changed how we talk about weight loss. Obesity was, and often still is, seen as a lifestyle problem rather than a chronic disease needing a chronic treatment. But in the frenzy surrounding the new-found popularity of this drug class, we still have a major unanswered question: What role do lifestyle interventions play in this new post-medication era?  Read More